FDA Classifies Anesthesiology Device for Opioid-Induced Impairment of Oxygenation

Summary

The FDA has classified the monitor for opioid-induced impairment of oxygenation into Class II, a move aimed at ensuring the device's safety and effectiveness while reducing regulatory burdens, ultimately enhancing patients' access to innovative devices.